POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway

Abstract

Objective

Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the head and neck, but its occurrence and progression mechanisms remain unclear. In addition-there is a lack of effective targeting drugs. The second major subunit of DNA polymerase (POLE2) catalyzes the prolongation of new strand replication and modifies exonuclease domain activity. Our previous study found that POLE2 was associated with OSCC progression, but the mechanism remains unclear.

Methods

The expression of POLE2 in OSCC tissues was detected using immunological assays. Mann-Whitney U analysis was used to investigate the relationship between POLE2 gene expression and tumor classification and prognosis of OSCC. POLE2 expression was inhibited in OSCC cells, and the effects of gene and protein expression were detected using RT-PCR and Western blotting. The POLE2 knockout model was constructed by transfecting a lentiviral vector. Cell proliferation, apoptosis, and migration were detected using various assays including colony formation, MTT, flow cytometry, wound healing assay, Transwell assay, and the Human Apoptosis Antibody Array. The animal model of OSCC was established by subcutaneous injection of transfected HN6 into 4-week-old female nude mice. After 30 days, tumors were removed under anesthesia and tumor weight and dimension were recorded. Tumor cell proliferation was analyzed using Ki67 staining.

Results

POLE2 gene levels were significantly higher in the OSCC tissues than in the normal tissues. In addition, POLE2 gene levels were statistically correlated with tumor classification and prognosis. Silencing POLE2 inhibited the proliferation of oral cancer cells and promoted apoptosis in vitro. Animal experiments also supported a positive correlation between POLE2 and OSCC tumor formation. We further demonstrated that POLE2 could upregulate the expression of apoptosis-related proteins such as caspase-3, CD40, CD40L, DR6, Fas, IGFBP-6, p21, and SMAC. In addition, POLE2 regulated OSCC development by inhibiting the PI3K/AKT signaling pathway.

Conclusion

POLE2 is closely related to the progression of OSCC. Thus, POLE2 may be a potential target for OSCC treatment.

Keywords

second major subunit of DNA polymerase / oral squamous cell carcinoma / PI3K/AKT

References

[1] BavleRM, VenugopalR, KondaP, et al.. Molecular Classification of Oral Squamous Cell Carcinoma. J Clin Diagn Res, 2016, 10(9): ZE18-ZE21

[2] ChenW, ZhengR, BaadeRD, et al.. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132

[3] AlmangushA, MakitieAA, TriantafyllouA, et al.. Staging and grading of oral squamous cell carcinoma: An update. Oral Oncol, 2020, 107: 104799

[4] ZhangWB, WangY, MaoC, et al.. Oral Squamous Cell Carcinoma with Metastasis to the Parotid Lymph Node. Chin J Dent Res, 2019, 22(3): 175-179

[5] BriggsS, TomlinsonI. Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol, 2013, 230(2): 148-153

[6] FrugoniF, DobbsK, FelgentreffK, et al.. A novel mutation in the POLE2 gene causing combined immunodeficiency. J Allergy Clin Immunol, 2016, 137(2): 635-638.e1

[7] SpierI, HolzapfelS, AltmullerJ, et al.. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer, 2015, 137(2): 320-331

[8] ZekriAR, HassanZK, BahnassyAA, et al.. Differentially expressed genes in metastatic advanced Egyptian bladder cancer. Asian Pac J Cancer Prev, 2015, 16(8): 3543-3549

[9] LiuD, ZhangXX, XiBX, et al.. Sine oculis homeobox homolog 1 promotes DNA replication and cell proliferation in cervical cancer. Int J Oncol, 2014, 45(3): 1232-1240

[10] HartmannE, FernandezV, MorenoV, et al.. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. J Clin Oncol, 2008, 26(30): 4966-4972

[11] WuZ, WangYM, DaiY, et al.. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer. Med Sci Monit, 2020, 26: e921430

[12] LiJ, WangJ, YuJ, et al.. Knockdown of POLE2 expression suppresses lung adenocarcinoma cell malignant phenotypes in vitro. Oncol Rep, 2018, 40(5): 2477-2486

[13] WuX, DengY. Bax and BH3-domain-only proteins in p53-mediated apoptosis. Front Biosci, 2002, 7: d151-156

[14] JurmeisterP, BockmayrM, et al.. Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification. J Dtsch Dermatol Ges, 2019, 17(8): 800-808

[15] KarimianA, AhmadiY, YousefiB. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst), 2016, 42: 63-71

[16] LiuC, VojnovicD, KochevarIE, et al.. UV-A Irradiation Activates Nrf2-Regulated Antioxidant Defense and Induces p53/Caspase3-Dependent Apoptosis in Corneal Endothelial Cells. Invest Ophthalmol Vis Sci, 2016, 57(4): 2319-2327

[17] MatsumuraY, HiraokaK, IshikawaK, et al.. CD40 Expression in Human Esophageal Squamous Cell Carcinoma Is Associated with Tumor Progression and Lymph Node Metastasis. Anticancer Res, 2016, 36(9): 4467-4475

[18] XueLY, RenLQ, LuoW, et al.. Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma. Zhonghua Yi Xue Za Zhi (Chinese), 2007, 87(3): 150-154

[19] QiaoD, XuJ, LeC, et al.. Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Lett, 2014, 230(3): 444-453

[20] XuY, ZhouL, HuangJ, et al.. Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma. Clin Cancer Res, 2011, 17(16): 5412-5422

[21] WeiJ, WuJ, XuW, et al.. Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α signaling pathway. Cell Death Dis, 2018, 9(6): 599

[22] Carlos de VicenteJ, Herrero-ZapateroA, FresnoMF, et al.. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol, 2002, 38(3): 301-308

[23] WalterV, YinX, WilkersonMD, et al.. Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes. PLoS One, 2018, 13(3): e0194674

[24] SamuelsY, WangZ, BardelliA, et al.. High frequency of mutations of the PIK3CA gene in human cancers. Science, 2004, 304(5670): 55

[25] XuS, GeJ, ZhangZ, et al.. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer. Biomed Pharmacother, 2017, 96: 634-641